ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,940Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 53

$352K Total Retail Price of All Prescriptions

Rank: 26 out of 53

475 Patients Receiving at Least One Drug in Part D
75% Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 24%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 595 500 86 1 8
OMEPRAZOLE 462 368 88 2 3
HYDROCHLOROTHIAZIDE 447 385 62 3 18
CARVEDILOL 376 294 65 4 13
METFORMIN HCL 280 209 43 5 9
LISINOPRIL 242 177 44 6 7
FUROSEMIDE 240 183 40 7 2
AMLODIPINE BESYLATE 235 187 36 8 4
HYDROCODONE-ACETAMINOPHEN 219 141 56 S3 9 1
GLIPIZIDE 210 151 27 10 47
MELOXICAM 190 150 47 11 21
TRAMADOL HCL 178 151 56 12 10
LEVOTHYROXINE SODIUM 177 156 26 13 5
FLUTICASONE PROPIONATE 176 139 124 14 55
ALLOPURINOL 171 146 33 15 42
WARFARIN SODIUM 157 138 26 16 14
METOPROLOL TARTRATE 147 125 23 17 16
LOSARTAN-HYDROCHLOROTHIAZIDE 147 113 19 17 53
AZITHROMYCIN 139 115 105 19 50
POTASSIUM CHLORIDE 127 99 20 20 6
DOXYCYCLINE HYCLATE 119 81 87 21 164
METOPROLOL SUCCINATE 116 98 20 22 29
NEXIUM 116 59 14 22 28
CRESTOR 108 103* 14 24 45
PRAVASTATIN SODIUM 103 78 17 25 17
TAMSULOSIN HCL 102 87 19 26 41
ATENOLOL 94 54 12 27 40
ZOLPIDEM TARTRATE 92 64 28 28 34
CYCLOBENZAPRINE HCL 88 56 26 R 29 49
FAMOTIDINE* 87 62 22 30 56
CELEBREX 81 67 11 31 82
GABAPENTIN 77 64 16 32 11
TRIAMTERENE-HCTZ 75 75 12 33 85
NAMENDA 74 74 12 34 12
GEMFIBROZIL 73 <11 <11 35 116
DOXAZOSIN MESYLATE 71 <11 <11 36 146
CLOTRIMAZOLE-BETAMETHASONE 70 49 40 37 239
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 <11 <11 38 38
CITALOPRAM HBR 64 51 12 39 23
CLONIDINE HCL 63 <11 <11 40 36
LORAZEPAM 63 58* 13 B 40 22
FENOFIBRATE* 61 <11 <11 42 105
ATORVASTATIN CALCIUM 57 <11 <11 43 19
CEPHALEXIN 56 51* 46 44 66
ZETIA 55 <11 <11 45 148
PANTOPRAZOLE SODIUM 52 28 12 46 24
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.